1. "Lymphoma"
Formats
  1. Meeting Abstract (1340)
  2. Journal Article (1048)
  3. Book Section (63)
  4. Review (63)
  5. Editorial (37)
  6. Research Letter (35)
  7. Guidelines (18)
  8. Conference Paper (15)
  9. Correspondence (11)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2639)
  2. Department of Medicine (2639)
  3. Hematologic Malignancies, Division of (2639)
  4. Lymphoma (2639)
  5. Population Sciences Research Program (720)
  6. Survivorship Research (633)

More Groups

People
  1. Andrew Zelenetz (767)
  2. Steven Horwitz (645)
  3. Maria Palomba (415)
  4. David Straus (356)
  5. Ariela Noy (351)
  6. Alison Moskowitz (339)

More People

Years
  1. 2025 (28)
  2. 2024 (100)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (833)
  2. Journal of Clinical Oncology (274)
  3. Hematological Oncology (110)
  4. Leukemia and Lymphoma (81)
  5. British Journal of Haematology (79)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (898)
  2. American Society of Clinical Oncology (290)
  3. Elsevier Inc. (187)
  4. Wiley Blackwell (173)
  5. John Wiley & Sons (95)
  6. Nature Publishing Group (92)

More Publishers

Results (2639)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and preliminary efficacy in patients (pts) with relapsed/refractory (R/R) mantle cell lymphoma (MCL) receiving lisocabtagene maraleucel (Liso-cel) in TRANSCEND NHL 001
    Meeting Abstract

    Wang, M.; Gordon, L. I.; Palomba, M. L.; Abramson, J. S.; Andreadis, C.; Ghosh, N.; Lunning, M. A.; Maloney, D. G.; Farazi, T. A.; Garcia, J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Patient-reported outcomes (PROs) with ibrutinib-rituximab in Waldenstrom macroglobulinemia (WM): Results from iNNOVATE
    Meeting Abstract

    Tedeschi, A.; Dimopoulos, M. A.; Trotman, J.; Garcia-Sanz, R.; MacDonald, D.; Mahe, B.; Herbaux, C.; Heffner, L. T.; Tam, C. S. L.; Varettoni, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Brentuximab vedotin with chemotherapy for stage 3/4 classical Hodgkin lymphoma: Three-year update of the ECHELON-1 study
    Meeting Abstract

    Straus, D. J.; Dlugosz-Danecka, M.; Alekseev, S.; Illes, A.; Picardi, M.; Lech-Maranda, E.; Feldman, T.; Savage, K. J.; Smolewski, P.; Bartlett, N. L.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Prediagnosis cardiovascular risk and subsequent myocardial infarction (Ml) among lymphoma survivors
    Meeting Abstract

    Salz, T.; Zabor, E. C.; de Nully Brown, P.; Dalton, S. O.; Raghunathan, N. J.; Matasar, M. J.; Steingart, R.; Hjalgrim, H.; Specht, L.; Oeffinger, K. C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Phase 1 study of CA-4948, a novel inhibitor of interleukin-1 receptor-associated kinase 4 (IRAK4) in patients (pts) with r/r non-Hodgkin lymphoma
    Meeting Abstract

    Rosenthal, A. C.; Tun, H. W.; Younes, A.; Nowakowski, G. S.; Lunning, M. A.; Patel, K.; Landsburg, D. J.; Martell, R. E.; Leslie, L. A.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Real-world assessment of practice efficiency with the introduction of subcutaneous rituximab
    Meeting Abstract

    Qiu, A.; Shapouri, S.; Drill, E. N.; Schade, J.; Ravelo, A.; Ni, A.; To, T. M.; Dawson, K. L.; Matasar, M. J.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Response to brentuximab vedotin by CD30 expression: Results from five trials in PTCL, CTCL, and B-cell lymphomas
    Meeting Abstract

    Jagadeesh, D.; Horwitz, S. M.; Bartlett, N. L.; Advani, R. H.; Jacobsen, E. D.; Duvic, M.; Gautam, A.; Rao, S.; Onsum, M.; Fanale, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3,546 women prospectively followed after receiving textured breast implants
    Meeting Abstract

    Ghione, P.; Cordeiro, P. G.; Ni, A.; Hu, Q. Y.; Ganesan, N.; Galasso, N.; Dogan, A.; Horwitz, S. M.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Managing cytokine release syndrome (CRS) and neurotoxicity with step-fractionated dosing of mosunetuzumab in relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (NHL)
    Meeting Abstract

    Bartlett, N. L.; Sehn, L. H.; Assouline, S. E.; Bosch, F.; Diefenbach, C. S. M.; Flinn, I.; Hong, J.; Kim, W. S.; Matasar, M. J.; Nastoupil, L. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Response to A+CHP by CD30 expression in the ECHELON-2 trial
    Meeting Abstract

    Advani, R. H.; Horwitz, S. M.; Iyer, S. P.; Bartlett, N. L.; Kim, W. S.; Tilly, H.; Belada, D.; Feldman, T.; IlleĢs, A.; Jacobsen, E. D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save